These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21339662)

  • 1. Phenytoin toxicity presenting as acute meningo-encephalitis in children.
    Gupta V; Yadav TP; Yadav A
    Neurol India; 2011; 59(1):66-7. PubMed ID: 21339662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical seizures in phenytoin toxicity.
    Chua HC; Venketasubramanian N; Tan CB; Tjia H
    Singapore Med J; 1999 Apr; 40(4):276-7. PubMed ID: 10487084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Temporal cerebellar atrophy following phenytoin therapy].
    Guerrero AL; Paniagua JA; Díaz Cascajo P; Cacho J; Arias P; Martín JA
    Neurologia; 1997; 12(6):259-61. PubMed ID: 9303595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phenytoin: paradoxical toxicity; a discussion of 4 cases].
    Pedreira Vázquez I; Outeda Macías M; Martín Herranz I
    Farm Hosp; 2003; 27(6):386-90. PubMed ID: 14974884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenytoin toxicity and thyroid dysfunction.
    Betteridge T; Fink J
    N Z Med J; 2009 Sep; 122(1303):102-4. PubMed ID: 19851414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenytoin toxicity: an easily missed cause of cerebellar syndrome.
    Brostoff JM; Birns J; McCrea D
    J Clin Pharm Ther; 2008 Apr; 33(2):211-4. PubMed ID: 18315788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of intravenous phenytoin toxicity with demographic, clinical, and dosing parameters.
    Binder L; Trujillo J; Parker D; Cuetter A
    Am J Emerg Med; 1996 Jul; 14(4):398-401. PubMed ID: 8768165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life-threatening cardiotoxicity due to chronic oral phenytoin overdose.
    Su CM; Kung CT; Wang YC; Lu CH
    Neurol India; 2009; 57(2):200-2. PubMed ID: 19439856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenytoin-induced visual disturbances mimicking Delirium Tremens in a child.
    Marín LL; García-Peñas JJ; Herguedas JL; Gutiérrez-Solana LG; Ruiz-Falcó M; Rodriguez AD; Extremera VC
    Eur J Paediatr Neurol; 2010 Sep; 14(5):460-3. PubMed ID: 20728059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iatrogenic behavioral and psychiatric symptoms in children with partial complex seizures.
    Parraga HC; Simonds JF; Butterfield PT
    J Dev Behav Pediatr; 1982 Mar; 3(1):25-8. PubMed ID: 7076859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenytoin desensitization in a child with symptomatic localization-related epilepsy.
    Itomi S; Okumura A; Ikuta T; Negoro T; Watanabe K
    Brain Dev; 2007 Mar; 29(2):121-3. PubMed ID: 16935446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebellar atrophy in an epileptic child: is it due to phenytoin?
    Ahuja SR; Karande S; Kulkarni MV
    J Postgrad Med; 2000; 46(4):278-9. PubMed ID: 11435657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenytoin: effective but insidious therapy for epilepsy in people with intellectual disability.
    Iivanainen M
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():24-31. PubMed ID: 10030428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent Michaelis-Menten kinetic parameters of phenytoin in pediatric patients.
    Chiba K; Ishizaki T; Miura H; Minagawa K
    Pediatr Pharmacol (New York); 1980; 1(2):171-80. PubMed ID: 7346739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of seizures from concomitant use of ciprofloxacin and phenytoin in patients with epilepsy.
    Springuel P
    CMAJ; 1998 Jan; 158(1):104-5, 108-9. PubMed ID: 9475922
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenytoin hypersensitivity syndrome masquerading as fever and systemic illness of unknown origin in an HIV-infected patient.
    Bedimo RJ; Geisler WM
    Int J STD AIDS; 2005 Feb; 16(2):178-9. PubMed ID: 15807950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum lipids. lipoproteins, and apolipoproteins in adult epileptics treated with carbamazepine, valproic acid, or phenytoin].
    Pita-Calandre E; Rodríguez-López CM; Cano MD; Peña-Bernal M
    Rev Neurol; 1998 Nov; 27(159):785-9. PubMed ID: 9859151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of drug therapy in epileptic children.
    Singh LM; Mehta S; Vohra RM; Nain CK
    Int J Clin Pharmacol Ther Toxicol; 1987 May; 25(5):251-4. PubMed ID: 3596850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenytoin-induced parkinsonism.
    Ertan S; Ulu MO; Hanimoglu H; Tanriverdi T; Kafadar AM; Acar ZU; Kiziltan G
    Singapore Med J; 2006 Nov; 47(11):981-3. PubMed ID: 17075669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
    Hernández R; Fernández Mde L; Miranda G; Suástegui R
    Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.